Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;71(1):133-40.
doi: 10.1016/j.jaad.2014.02.012. Epub 2014 Apr 4.

Diet and psoriasis, part I: Impact of weight loss interventions

Maya Debbaneh  1 , Jillian W Millsop  2 , Bhavnit K Bhatia  3 , John Koo  4 , Wilson Liao  4
Affiliations
Review

Diet and psoriasis, part I: Impact of weight loss interventions

Maya Debbaneh et al. J Am Acad Dermatol. 2014 Jul.

Abstract

One of the most frequently asked questions by patients with psoriasis is whether dietary changes can improve their condition. Included in this discussion is whether dietary weight loss can benefit their skin disease. Obesity has been associated with a proinflammatory state and several studies have demonstrated a relationship between body mass index and psoriasis severity. However, the question of whether weight loss interventions can impact psoriasis outcome is less clear. Here, we review the literature to examine the efficacy of weight loss interventions, both dietary and surgical, on psoriasis disease course.

Keywords: body mass index; diet; gastric bypass; nutrition; obesity; psoriasis; weight loss.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Dr. John Koo is a speaker for AbbVie and Leo. Dr. Koo conducts research for Amgen, Janssen, Novartis, Photomedex, Galderma, Pfizer, and Merck. Dr. Koo has no stocks, employment, or board memberships with any pharmaceutical company. None of the grants were directly related to this study. No other authors have conflicts of interest to report.

Comment in

References

    1. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14:485–96. - PubMed
    1. Stern RS. Psoriasis. Lancet. 1997;350:349–53. - PubMed
    1. Davidovici BB, Sattar N, Prinz JC, Jörg PC, Puig L, Emery P, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130:1785–96. - PubMed
    1. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. International journal of obesity. 2009;33:151–6. - PubMed
    1. Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol. 2003;49:S57–61. - PubMed

Publication types